Graph representation learning in biomedicine and healthcare

MM Li, K Huang, M Zitnik - Nature Biomedical Engineering, 2022 - nature.com
Networks—or graphs—are universal descriptors of systems of interacting elements. In
biomedicine and healthcare, they can represent, for example, molecular interactions …

How can natural language processing help model informed drug development?: a review

R Bhatnagar, S Sardar, M Beheshti, JT Podichetty - JAMIA open, 2022 - academic.oup.com
Objective To summarize applications of natural language processing (NLP) in model
informed drug development (MIDD) and identify potential areas of improvement. Materials …

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

D Bang, S Lim, S Lee, S Kim - Nature Communications, 2023 - nature.com
Computational drug repurposing aims to identify new indications for existing drugs by
utilizing high-throughput data, often in the form of biomedical knowledge graphs. However …

Affinity2Vec: drug-target binding affinity prediction through representation learning, graph mining, and machine learning

MA Thafar, M Alshahrani, S Albaradei, T Gojobori… - Scientific reports, 2022 - nature.com
Drug-target interaction (DTI) prediction plays a crucial role in drug repositioning and virtual
drug screening. Most DTI prediction methods cast the problem as a binary classification task …

Modality-DTA: multimodality fusion strategy for drug–target affinity prediction

X Yang, Z Niu, Y Liu, B Song, W Lu… - … /ACM Transactions on …, 2022 - ieeexplore.ieee.org
Prediction of the drug–target affinity (DTA) plays an important role in drug discovery. Existing
deep learning methods for DTA prediction typically leverage a single modality, namely …

Ammvf-dti: A novel model predicting drug–target interactions based on attention mechanism and multi-view fusion

L Wang, Y Zhou, Q Chen - International Journal of Molecular Sciences, 2023 - mdpi.com
Accurate identification of potential drug–target interactions (DTIs) is a crucial task in drug
development and repositioning. Despite the remarkable progress achieved in recent years …

A deep learning model predicts the presence of diverse cancer types using circulating tumor cells

S Albaradei, N Alganmi, A Albaradie, E Alharbi… - Scientific reports, 2023 - nature.com
Circulating tumor cells (CTCs) are cancer cells that detach from the primary tumor and
intravasate into the bloodstream. Thus, non-invasive liquid biopsies are being used to …

Drug repurposing in silico screening platforms

JGL Mullins - Biochemical Society Transactions, 2022 - portlandpress.com
Over the last decade, for the first time, substantial efforts have been directed at the
development of dedicated in silico platforms for drug repurposing, including initiatives …

Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential driver genes

S Li, X Chen, J Chen, B Wu, J Liu, Y Guo, M Li… - Computers in Biology …, 2023 - Elsevier
G protein-coupled receptors (GPCRs) are the largest drug target family. Unfortunately,
applications of GPCRs in cancer therapy are scarce due to very limited knowledge …

A new framework for drug–disease association prediction combing light-gated message passing neural network and gated fusion mechanism

BM Liu, YL Gao, DJ Zhang, F Zhou… - Briefings in …, 2022 - academic.oup.com
With the development of research on the complex aetiology of many diseases,
computational drug repositioning methodology has proven to be a shortcut to costly and …